关键信息
-
基因名
hlgC
- 应用
-
别名
hlgC；Gamma-hemolysin component C
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7A3S2
-
表达区间
30-315aa
-
氨基酸序列
ANDTEDIGKGSDIEIIKRTEDKTSNKWGVTQNIQFDFVKDKKYNKDALILKMQGFISSRTTYYNYKKTNHVKAMRWPFQYNIGLKTNDKYVSLINYLPKNKIESTNVSQTLGYNIGGNFQSAPSLGGNGSFNYSKSISYTQQNYVSEVEQQNSKSVLWGVKANSFATESGQKSAFDSDLFVGYKPHSKDPRDYFVPDSELPPLVQSGFNPSFIATVSHEKGSSDTSEFEITYGRNMDVTHAIKRSTHYGNSYLDGHRVHNAFVNRNYTVKYEVNWKTHEIKVKGQN
-
分子量
39.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
HlgC is a member of the Hlg (hemolysin glycoprotein) family, which is known for its role in bacterial virulence. Research on HlgC has gained attention due to its involvement in various pathogenic processes in bacteria, particularly in relation to its immunogenic properties and potential applications in vaccine development. As a glycoprotein, HlgC may play a crucial role in the adherence of bacteria to host cells, facilitating infection and contributing to the spread of diseases. Understanding the structural and functional aspects of HlgC can provide insights into its mechanisms of action and interactions with the host's immune system. Recent studies have focused on the recombinant expression of HlgC, allowing for the production of large quantities of the protein for further analysis. This research aims to elucidate the protein's structure, function, and its potential as a target for therapeutic interventions. By characterizing HlgC, researchers hope to advance the development of novel strategies to combat bacterial infections and enhance the efficacy of existing vaccines. The exploration of HlgC and its pathways not only contributes to our understanding of bacterial pathogenesis but also holds promise for improving public health outcomes through targeted immunotherapies.
